The X chromosome and systemic sclerosis

Current Opinion in Rheumatology

Volumn 18, Issue 6, 2006, Pages 601-605

  Selmi, Carlo ^a,b   Invernizzi, Pietro ^c   Gershwin, M Eric ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Haploinsufficiency; X chromosome inactivation; X monosomy

Indexed keywords

AUTOIMMUNE DISEASE; BLOOD; CHROMOSOME ANALYSIS; CHROMOSOME INACTIVATION; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; MICROCHIMERISM; MONOSOMY X; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS; X CHROMOSOME;

AUTOIMMUNITY; CHROMOSOMES, HUMAN, X; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MONOSOMY; SCLERODERMA, SYSTEMIC; X CHROMOSOME INACTIVATION;

EID: 33750200610     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000245718.56770.a4     Document Type: Review

References (38)

1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140:37-50.
2. Herrick AL, Worthington J. Genetic epidemiology: systemic sclerosis. Arthritis Res 2002; 4:165-168.
3. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003; 48:1956-1963.
4. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2:777-780.
5. Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci U S A 1994; 91:5382-5386.
6. Smithson G, Beamer WG, Shultz KL, et al. Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J Exp Med 1994; 180:717-720.
7. Grimaldi CM, Cleary J, Dagtas AS, et al. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002; 109:1625-1633.
8. Black CM, Stevens WM. Scleroderma. Rheum Dis Clin North Am 1989; 15:193-212.
9. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338:1186-1191.
10. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351:559-562.
11. Murata H, Nakauchi H, Sumida T. Microchimerism in Japanese women patients with systemic sclerosis [letter]. Lancet 1999; 354:220.
12. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001; 358:309-314.
13. Davis CJ, Davison RM, Payne NN, et al. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum Reprod 2000; 15:2418-2422.
14. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. Immunol Rev 2005; 203:156-164.
15. Tan SS, Williams EA, Tam PP. X-chromosome inactivation occurs at different times in different tissues of the postimplantation mouse embryo. Nat Genet 1993; 3:170-174.
16. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. Xist RNA and the mechanism of X chromosome inactivation. Annu Rev Genet 2002; 36:233-278.
17. Grati FR, Sirchia SM, Gentilin B, et al. Biparental expression of ESX1L gene in placentas from normal and intrauterine growth-restricted pregnancies. Eur J Hum Genet 2004; 12:272-278.
18. Lanasa MC, Hogge WA, Hoffman EP. Sex Chromosome Genetics '99. The X chromosome and recurrent spontaneous abortion: the significance of transmanifesting carriers. Am J Hum Genet 1999; 64:934-938.
19. Brown CJ, Robinson WP. The causes and consequences of random and nonrandom X chromosome inactivation in humans. Clin Genet 2000; 58:353-363.
20. Asplund A, Guo Z, Hu X, et al. Mosaic pattern of maternal and paternal keratinocyte clones in normal human epidermis revealed by analysis of X-chromosome inactivation. J Invest Dermatol 2001; 117:128-131.
21. Hatakeyama C, Anderson CL, Beever CL, et al. The dynamics of X-inactivation skewing as women age. Clin Genet 2004; 66:327-332.
22. Sharp A, Robinson D, Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 2000; 107:343-349.
23. Balmer D, LaSalle JM. Clonal maintenance of imprinted expression of SNRPN and IPW in normal lymphocytes: correlation with allele-specific methylation of SNRPN intron 1 but not intron 7. Hum Genet 2001; 108:116-122.
24. Migeon BR, Axelman J, Jeppesen P. Differential x reactivation in human placental cells: implications for reversal of x inactivation. Am J Hum Genet 2005; 77:355-364.
25. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434:400-404. An enormous molecular undertaking that allowed one to define and quantitate the inactivation pattern of 99% of the X chromosome in a small population of healthy women.
26. Ozbalkan Z, Bagislar S, Kiraz S, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005; 52:1564-1570. The first reported evidence of a skewed X chromosome inactivation pattern in women with SSc.
27. McGrath H Jr. Skewed X chromosome inactivation in scleroderma: comment on the article by Ozbalkan et al. [letter] Arthritis Rheum 2005; 52:3679; author reply 3679-3680.
28. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998; 19:352-357.
29. Brix TH, Knudsen GP, Kristiansen M, et al. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005; 90:5949-5953.
30. Ozcelik T, Uz E, Akyerli CB, et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006; 14:791-797.
31. Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 2003; 29:211-237.
32. Invernizzi P, Miozzo M, Battezzati PM, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004; 363:533-535.
33. Invernizzi P, Miozzo M, Selmi C, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005; 175:575-578. An in-situ hybridization study that demonstrated for the first time an enhanced X monosomy in peripheral blood cells of women with SSc and suggested common mechanisms for autoimmunity sex ratios.
34. Kim WU, Min SY, Cho ML, et al. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 2005; 7:R71-R79.
35. Ashour K, Shan L, Lee JH, et al. Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. Am J Respir Crit Care Med 2006; 173:1377-1385.
36. Helmbold P, Fiedler E, Fischer M, Marsch W. Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol 2004; 31:431-440.
37. Sato S, Sanjo H, Takeda K, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005; 6:1087-1095.
38. Wick G, Andersson L, Hala K, et al. Avian models with spontaneous autoimmune diseases. Adv Immunol (in press).